merger news from FierceBiotech
News
Report: Wilex, GPC nearing merger pact
Two German biotech companies which share a very big investor are preparing to merge, according to a prominent German newspaper. Wilex and GPC Biotech, both involved in developing new cancer Read more...
SPOTLIGHT: Mystery Mistral merger is off
Canada's Mistral Pharma says its proposed merger with an unnamed U.S. specialty pharma company will not be completed. As a result, its bridge financing deal has been canceled and management has Read more...
Struggling VaxGen sells anthrax vaccine to rival
After spending $175 million in an unsuccessful effort to push a new anthrax vaccine into the clinic, VaxGen has sold the program to Emergent BioSolutions for $2 million. VaxGen also stands to earn Read more...
Critical Therapeutics, Cornerstone to merge
Critical Therapeutics is merging with Cornerstone Read more...
Struggling VaxGen goes skeletal with cutbacks
With its planned merger involving Raven Biotechnologies on the rocks, a struggling VaxGen is Read more...
Viventia considers sale/merger in strategic review
Viventia Biotech is also going the way of the strategic review, promising to consider its sale or merger options as it advances new antibody therapies for cancer. HSBC has been brought in to advise Read more...
Dealmaking stays big even as the markets tremble
The credit crunch could play a miserly role in hobbling biotech, but I have yet to see it. As long as big pharma sees its future in biologics, you can expect to see investors laying their bets to Read more...
Merck chief defines the perfect biotech buyout
Just before Biogen Idec announced it was out of the merger business, for the present, Merck's CEO was telling the Wall Street Journal that it had Read more...
Nabi explores "strategic alternatives"
Nabi Biopharmaceuticals has approved the repurchase of up to $65 million of the company's outstanding common shares in the open market or in privately negotiated transactions. The company said its Read more...
Get more merger coverage at:
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight